Watchlist

Watchlist
Alder BioPharmaceuticals, Inc. (ALDR)
Alder BioPharmaceuticals, Inc. (ALDR)
Teva's pain is Alder's gain in migraine; shares up 15%
Alder Biopharma ( ALDR +14.8% ) is up on almost 40% higher volume as investors believe that Teva's exit from developing CGRP inhibitor fremenezumab for chronic cluster headache is a positive for Alder's CGRP inhibitor eptinezumab, in Phase 3 development for chronic and episodic migraine. …
Alder BioPharmaceuticals, Inc. (ALDR)